In pancreatic cancer, expression of claudin-4 was associated with significant reduction of in-vitro invasive potential, inhibition of colony formation, as well as reduction of in-vivo metastases [51]. The gene discussed is CLDN4; the disease is familial pancreatic carcinoma.